GLUCOSE ISOMERASE (IMMOBILIZED) FROM STREPTOMYCES OLIVOCHROMOGENES EXPLANATION This substance has not been previously evaluated by the Joint FAO/WHO Expert Committee on Food Additives. BIOLOGICAL DATA Biochemical aspects No information available. Toxicological studies Acute toxicity No information available. Short-term studies Rats Groups of 15 male and 15 female Charles-River albino rats were fed 0, 1, 3, or 10% of a preparation of whole S. olivochromogenes cells in the diet for 90 days. Harvesting of the cells for the feeding studies was performed by the addition of 36 g/litre of Perlite to the fermentation media followed by filtration and washing. (A semipurified enzyme preparation from lysed cells - no Perlite added - is used in the actual commercial production of high fructose corn syrup.) An additional group of 15 males and 15 females were fed a diet containing 7.5% Perlite for 90 days. Clinical chemistry, haematology, urinalysis, and microscopic pathology were conducted on 10 animals/sex from the control, Perlite, and high-dose groups. There was a small decrease in liver to body-weight ratio in all treatment groups and in the Perlite groups. The decreases were not dose-related. Spleen to body-weight ratios were decreased in mid- and high-dose females, but the magnitude of the effect was small. There was an increase in ovary to body-weight ratio in low- and high-dose females, but there was an inverse dose relationship and the magnitude of the effect was small. No treatment-related changes were reported with respect to body-weight gain, food consumption, haematology, clinical chemistry, urinalysis, or gross or microscopic pathology (Smith, 1972). Dogs Groups of 4 male and 4 female beagle dogs were fed diets containing 0, 1, 3, or 10% of a S. olivochromogenes whole-cell preparation similar to that described above in the rat study. An additional group of 4 males and 4 females were fed a diet containing 7.5% Perlite. A significant reduction in body-weight gain was observed in the male high-dose group. No statistically-significant effects of treatment on food consumption were reported, but there appeared to be a dose-related trend toward lower food consumption in females. An increased brain to body-weight ratio in high-dose and diluent-control males was probably due to the reduced body-weight gain in these groups. No significant treatment-related changes were reported with respect to haematology, clinical chemistry, urinalysis, or gross or microscopic pathology (Burtner, 1972). Comments Short-term feeding studies in rats and dogs showed no significant toxicological effects. Although the preparation fed in these studies differs from that used in commercial preparations, the high levels of whole cells fed (up to 10% of the diet) plus the use of a Perlite control provide adequate information for evaluating the safety of the preparation derived from lysed cells. EVALUATION Level causing no toxicological effect Rat: 10% (100,000 ppm) in the diet, equivalent to 10,000 mg/kg b.w./day. Estimate of acceptable daily intake for man Acceptable for use in food processing when used as a component in an immobilized system. REFERENCES Burtner, B.R. (1972). Ninety-day subacute oral toxicity study with XSO-1228 in Beagle dogs. Unpublished report of Industrial BIO-TEST Laboratories, Inc. Submitted to the World Health Organization by CPC International, Inc. (validated study). Smith, P.S. (1972). Ninety-day subacute oral toxicity study with XSO 1228 in albino rats. Unpublished report of Industrial BIO-TEST Laboratories, Inc. Submitted to the World Health Organization by CPC International, Inc. (validated study).
See Also: Toxicological Abbreviations